Investor interest in companies with obesity candidates in their pipeline clearly remains high, given that a brand new ...

Financing was co-led by Forbion and General Atlantic, with participants such as RA Capital Management, OrbiMed, and Lilly Asia Ventures.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...

Britain's Terry Smith made public for the first time why Fundsmith Equity Fund dumped its Diageo stake last year.

While campaigning for Donald Trump in October, Elon Musk claimed he could slash “at least $2 trillion” in government spending ...